Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)

✍ Scribed by Skrivanek, Z.; Gaydos, B. L.; Chien, J. Y.; Geiger, M. J.; Heathman, M. A.; Berry, S.; Anderson, J. H.; Forst, T.; Milicevic, Z.; Berry, D.

• Book ID: 121861549
• Publisher: John Wiley and Sons
• Year: 2014
• Tongue: English
• Weight: 745 KB
• Volume: 16
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/dom.12305